Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600767.SS Stock Summary
In the News
600767.SS Financial details
Company Rating
Neutral
Market Cap
143.22M
Income
-38.31M
Revenue
43.6M
Book val./share
0.57
Cash/share
0.15
Dividend
-
Dividend %
-
Employees
53
Optionable
No
Shortable
Yes
Earnings
27 Apr 2021
P/E
-3.73
Forward P/E
-
PEG
0.06
P/S
3.28
P/B
0.73
P/C
-
P/FCF
-3.72
Quick Ratio
1.4
Current Ratio
1.55
Debt / Equity
0.06
LT Debt / Equity
0.03
-
-
EPS (TTM)
-0.11
EPS next Y
-
EPS next Q
-
EPS this Y
-600%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-25.92%
Revenue Q/Q
-39.19%
EPS Q/Q
-83.73%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-17%
ROC
-0.18%
Gross Margin
50%
Oper. Margin
-88%
Profit Margin
-88%
Payout
-1%
Shs Outstand
341.01M
Shs Float
248.1M
-
-
-
-
Target Price
-
52W Range
0.38-6.38
52W High
-
52W Low
-
RSI
-
Rel Volume
3.55
Avg Volume
6.43M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.561301
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
600767.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.61 | 0.39 | 0.14 | 0.14 | 0.14 | |
Net income per share | 0.06 | -0.24 | 0.03 | 0.04 | -0.1 | |
Operating cash flow per share | -0.12 | -0.12 | 0.11 | 0.01 | -0.04 | |
Free cash flow per share | -0.2 | -0.14 | 0.11 | 0.01 | -0.04 | |
Cash per share | 0.3 | 0.11 | 0.11 | 0.11 | 0.2 | |
Book value per share | 0.84 | 0.63 | 0.65 | 0.65 | 0.59 | |
Tangible book value per share | 0.4 | 0.54 | 0.54 | 0.59 | 0.53 | |
Share holders equity per share | 0.84 | 0.63 | 0.65 | 0.65 | 0.59 | |
Interest debt per share | 0.01 | 0.03 | 0.01 | 0.02 | 0.04 | |
Market cap | 1.62B | 1.63B | 984.6M | 2.8B | 1.6B | |
Enterprise value | 1.54B | 1.59B | 940.27M | 2.76B | 1.56B | |
P/E ratio | 79.17 | -19.79 | 102.14 | 206.24 | -45.15 | |
Price to sales ratio | 7.79 | 12.28 | 20.23 | 54.02 | 34.5 | |
POCF ratio | -40.37 | -38.74 | 26.8 | 841.72 | -117.76 | |
PFCF ratio | -24.06 | -34.74 | 27.2 | 1.03K | -116.88 | |
P/B Ratio | 5.64 | 7.6 | 4.4 | 11.54 | 7.92 | |
PTB ratio | 5.64 | 7.6 | 4.4 | 11.54 | 7.92 | |
EV to sales | 7.41 | 11.99 | 19.32 | 53.27 | 33.72 | |
Enterprise value over EBITDA | 36.16 | -99.43 | 39.57 | 119.08 | 223.42 | |
EV to operating cash flow | -38.41 | -37.81 | 25.59 | 830.02 | -115.11 | |
EV to free cash flow | -22.89 | -33.91 | 25.98 | 1.02K | -114.25 | |
Earnings yield | 0.01 | -0.05 | 0.01 | 0 | -0.02 | |
Free cash flow yield | -0.04 | -0.03 | 0.04 | 0 | -0.01 | |
Debt to equity | 0.01 | 0.03 | 0 | 0.03 | 0.07 | |
Debt to assets | 0.01 | 0.02 | 0 | 0.02 | 0.04 | |
Net debt to EBITDA | -1.85 | 2.44 | -1.87 | -1.68 | -5.16 | |
Current ratio | 1.74 | 1.48 | 1.38 | 1.82 | 1.54 | |
Interest coverage | 22.2 | -15.92 | 13.1 | 34.49 | -0.03 | |
Income quality | -1.96 | 0.51 | 3.45 | 0.22 | 0.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.02 | -0.02 | 0.13 | 0.08 | -0.01 | |
Sales general and administrative to revenue | 0.11 | 0.19 | 0.13 | 0.09 | 0.31 | |
Research and developement to revenue | 0.04 | 0.07 | 0 | 0 | 0 | |
Intangibles to total assets | 0.38 | 0.13 | 0.12 | 0.08 | 0.06 | |
Capex to operating cash flow | 0.68 | 0.11 | -0.01 | -0.18 | 0.01 | |
Capex to revenue | -0.13 | -0.04 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -1.85 | -0.28 | -0.07 | -0.09 | -0.01 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.07 | 1.85 | 0.64 | 0.73 | 1.17 | |
ROIC | 0.03 | -0.18 | 0.05 | 0.05 | 0 | |
Return on tangible assets | 0.07 | -0.25 | 0.03 | 0.05 | -0.12 | |
Graham Net | -0.14 | -0.02 | -0.04 | 0.06 | 0.07 | |
Working capital | 102.98M | 61.36M | 33.41M | 53.42M | 44.54M | |
Tangible asset value | 137.45M | 183.66M | 186.93M | 220.08M | 182.02M | |
Net current asset value | 73.68M | 43.01M | 14.93M | 48.06M | 24.65M | |
Invested capital | 0.01 | 0.03 | 0 | 0.03 | 0.07 | |
Average receivables | 0 | 62.2M | 94.89M | 65.77M | 67.22M | |
Average payables | 49.12M | 37M | 30.25M | 23.53M | 9.38M | |
Average inventory | 37.45M | 24.36M | 11.14M | 6.39M | 6M | |
Days sales outstanding | 0 | 342.7 | 490.2 | 465.69 | 538.83 | |
Days payables outstanding | 160.36 | 80.76 | 610.1 | 148.13 | 165.96 | |
Days of inventory on hand | 107.49 | 50.91 | 131.71 | 76.18 | 124.53 | |
Receivables turnover | 0 | 1.07 | 0.74 | 0.78 | 0.68 | |
Payables turnover | 2.28 | 4.52 | 0.6 | 2.46 | 2.2 | |
Inventory turnover | 3.4 | 7.17 | 2.77 | 4.79 | 2.93 | |
ROE | 0.07 | -0.38 | 0.04 | 0.06 | -0.18 | |
Capex per share | -0.08 | -0.01 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.02 | 0.02 | 0.05 | 0.03 | 0.02 | |
Net income per share | -0.01 | 0 | 0.02 | -0.11 | -0.02 | |
Operating cash flow per share | -0.06 | 0 | 0.02 | -0.11 | -0.02 | |
Free cash flow per share | -0.06 | 0 | 0.02 | -0.11 | -0.02 | |
Cash per share | 0.11 | 0.11 | 0.12 | 0.2 | 0.15 | |
Book value per share | 0.61 | 0.61 | 0.63 | 0.59 | 0.57 | |
Tangible book value per share | 0.56 | 0.56 | 0.58 | 0.53 | 0.52 | |
Share holders equity per share | 0.61 | 0.61 | 0.63 | 0.59 | 0.57 | |
Interest debt per share | 0.05 | 0.04 | 0.06 | 0.04 | 0.04 | |
Market cap | 2.55B | 1.53B | 2.11B | 1.6B | 1.89B | |
Enterprise value | 2.55B | 1.53B | 2.11B | 1.56B | 1.87B | |
P/E ratio | -146.41 | -278.2 | 81.21 | -10.68 | -77.54 | |
Price to sales ratio | 273.41 | 197.4 | 116.41 | 145.11 | 282.57 | |
POCF ratio | -114.9 | -1.11K | 324.84 | -42.71 | -310.16 | |
PFCF ratio | -114.87 | -1.1K | 326.75 | -42.66 | -303.26 | |
P/B Ratio | 10.68 | 6.44 | 8.66 | 7.92 | 9.66 | |
PTB ratio | 10.68 | 6.44 | 8.66 | 7.92 | 9.66 | |
EV to sales | 272.79 | 196.75 | 116.24 | 141.84 | 279.7 | |
Enterprise value over EBITDA | -639.43 | -847.01 | 248.34 | -563.41 | -369.34 | |
EV to operating cash flow | -114.64 | -1.11K | 324.38 | -41.75 | -307.01 | |
EV to free cash flow | -114.61 | -1.1K | 326.28 | -41.7 | -300.19 | |
Earnings yield | 0 | 0 | 0 | -0.02 | 0 | |
Free cash flow yield | -0.01 | 0 | 0 | -0.02 | 0 | |
Debt to equity | 0.08 | 0.07 | 0.09 | 0.07 | 0.06 | |
Debt to assets | 0.06 | 0.05 | 0.07 | 0.04 | 0.04 | |
Net debt to EBITDA | 1.45 | 2.78 | -0.36 | 13.01 | 3.79 | |
Current ratio | 1.88 | 1.91 | 1.79 | 1.54 | 1.55 | |
Interest coverage | -13.21 | -8.73 | 20.61 | -86.6 | -38.29 | |
Income quality | 5.7 | 1 | 1 | 1 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.01 | -0.04 | 0.02 | 0 | 0 | |
Sales general and administrative to revenue | 0.97 | -0.08 | 0.57 | -0.4 | 1.17 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.08 | 0.07 | 0.06 | 0.06 | 0.07 | |
Capex to operating cash flow | 0 | 0.01 | -0.01 | 0 | 0.02 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.02 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.39 | 0.22 | 0.49 | 1.2 | 0.48 | |
ROIC | -0.02 | -0.01 | 0.03 | -0.17 | -0.03 | |
Return on tangible assets | -0.02 | 0 | 0.02 | -0.13 | -0.02 | |
Graham Net | 0.08 | 0.08 | 0.09 | 0.07 | 0.05 | |
Working capital | 47M | 46.9M | 54.12M | 44.54M | 35.71M | |
Tangible asset value | 216.95M | 216.9M | 225.92M | 182.02M | 177.15M | |
Net current asset value | 32.79M | 33.48M | 40.64M | 24.65M | 17.14M | |
Invested capital | 0.08 | 0.07 | 0.09 | 0.07 | 0.06 | |
Average receivables | 0 | 70.49M | 80.78M | 79.57M | 64.34M | |
Average payables | 0 | 10.69M | 10.52M | 10.28M | 7.36M | |
Average inventory | 0 | 4.47M | 4.46M | 5.98M | 7.82M | |
Days sales outstanding | 677.87 | 820.58 | 450.15 | 558.9 | 813.23 | |
Days payables outstanding | 207.1 | 167.63 | 193.12 | 134.55 | 97.44 | |
Days of inventory on hand | 85.08 | 71.27 | 81.74 | 100.95 | 168.14 | |
Receivables turnover | 0.13 | 0.11 | 0.2 | 0.16 | 0.11 | |
Payables turnover | 0.43 | 0.54 | 0.47 | 0.67 | 0.92 | |
Inventory turnover | 1.06 | 1.26 | 1.1 | 0.89 | 0.54 | |
ROE | -0.02 | -0.01 | 0.03 | -0.19 | -0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
600767.SS Frequently Asked Questions
What is Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock symbol ?
Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a CN stock and trading under the symbol 600767.SS
What is Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock quote today ?
Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock price is $- today.
Is Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock public?
Yes, Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a publicly traded company.